4//SEC Filing
MACARTNEY LAWSON 4
Accession 0001209191-23-024725
CIK 0001607678other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 7:10 PM ET
Size
8.8 KB
Accession
0001209191-23-024725
Insider Transaction Report
Form 4
MACARTNEY LAWSON
Director
Transactions
- Sale
Common Stock, par value $0.00001 per share
2023-04-17$20.00/sh−20,786$415,720→ 47,965 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-04-17−20,786→ 0 totalExercise: $8.00From: 2016-05-26Exp: 2025-04-28→ Common Stock (20,786 underlying) - Exercise/Conversion
Common Stock, par value $0.00001 per share
2023-04-17$8.00/sh+20,786$166,288→ 68,751 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person.
- [F2]100% of the shares subject to the option vested on May 26, 2016, the date of the Issuer's first Annual Meeting of Stockholders following the date of grant.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001606831
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 7:10 PM ET
- Size
- 8.8 KB